Ripple Therapeutics

Ripple Therapeutics: Contact Details and Business Profile

Signing of an exclusive Licensing Agreement with Ripple Therapeutics Corp. - Théa Open Innovation

OIS XII Presenting Companies Ophthalmology Innovation Source

Ripple Therapeutics

Ripple Therapeutics Treats First Patient in Phase II Trial of DME, RVO Candidate

Ripple Therapeutics

BioTuesdays on X: This week's feature - Ripple Therapeutics inked a transformative strategic investment and licensing deal for its lead candidate, IBE-814 IVT, an intravitreal implant being developed for the treatment of

Our Science - Molecular Design Meets Material Science

Ripple Therapeutics - Tom Reeves, President & CEO

Tom Reeves email address & phone number Ripple Therapeutics President and CEO contact information - RocketReach